Cargando…

Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA

The development of cervical cancer is frequently accompanied by the integration of human papillomaviruses (HPV) DNA into the host genome. Viral-cellular junction sequences, which arise in consequence, are highly tumor specific. By using these fragments as markers for tumor cell origin, we examined c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carow, Katrin, Gölitz, Mandy, Wolf, Maria, Häfner, Norman, Jansen, Lars, Hoyer, Heike, Schwarz, Elisabeth, Runnebaum, Ingo B., Dürst, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666714/ https://www.ncbi.nlm.nih.gov/pubmed/28937589 http://dx.doi.org/10.3390/ijms18102032

Ejemplares similares

A comparative study of digital PCR and real-time qPCR for the detection and quantification of HPV mRNA in sentinel lymph nodes of cervical cancer patients
por: Carow, Katrin, et al.
Publicado: (2017)

A Promising DNA Methylation Signature for the Triage of High-Risk Human Papillomavirus DNA-Positive Women
por: Hansel, Alfred, et al.
Publicado: (2014)

Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants
por: Heinze, Karolin, et al.
Publicado: (2018)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Differences in Stability of Viral and Viral-Cellular Fusion Transcripts in HPV-Induced Cervical Cancers
por: Ehrig, Franziska, et al.
Publicado: (2019)

Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women
por: Schmitz, Martina, et al.
Publicado: (2017)

Digital-Direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma
por: Pfitzner, Claudia, et al.
Publicado: (2014)

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms
por: Hildebrandt, Jana, et al.
Publicado: (2022)

Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
por: Paschold, Lisa, et al.
Publicado: (2022)

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues
por: Hildebrandt, Jana, et al.
Publicado: (2022)

Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status
por: Dürst, Matthias, et al.
Publicado: (2015)

MEDB-66. Investigating intra-tumoral heterogeneity of extrachromosomal DNA in SHH medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022)

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients
por: Heinze, Karolin, et al.
Publicado: (2021)

Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays
por: Dippmann, Carolin, et al.
Publicado: (2020)

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer
por: Grassi, Tommaso, et al.
Publicado: (2021)

Non-Random Integration of the HPV Genome in Cervical Cancer
por: Schmitz, Martina, et al.
Publicado: (2012)

THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data
por: Oesper, Layla, et al.
Publicado: (2013)

Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer
por: Younes, Shadi, et al.
Publicado: (2021)

Breast cancer intra-tumor heterogeneity
por: Martelotto, Luciano G, et al.
Publicado: (2014)

Collaborative intra-tumor heterogeneity detection
por: Khakabimamaghani, Sahand, et al.
Publicado: (2019)

Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
por: Gao, Jing, et al.
Publicado: (2017)

Single-cell DNA and RNA sequencing reveals the dynamics of intra-tumor heterogeneity in a colorectal cancer model
por: Ono, Hanako, et al.
Publicado: (2021)

Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
por: Barth, Marie-Christin, et al.
Publicado: (2023)

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
por: Myint, Ni Ni Moe, et al.
Publicado: (2018)

Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma
por: Gill, Andrew B., et al.
Publicado: (2020)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Intra-tumor Genetic Heterogeneity in Rectal Cancer
por: Hardiman, Karin M., et al.
Publicado: (2015)

Overview on Clinical Relevance of Intra-Tumor Heterogeneity
por: Stanta, Giorgio, et al.
Publicado: (2018)

Addressing intra-tumoral heterogeneity and therapy resistance
por: Rybinski, Brad, et al.
Publicado: (2016)

SORBS2 and TLR3 induce premature senescence in primary human fibroblasts and keratinocytes
por: Liesenfeld, Melanie, et al.
Publicado: (2013)

Gene expression-based dissection of inter-histotypes, intra-histotype and intra-tumor heterogeneity in pediatric tumors
por: Ciceri, Sara, et al.
Publicado: (2022)

Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB
por: Fridland, Stanislav, et al.
Publicado: (2021)

Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance
por: Pecorino, Lauren T., et al.
Publicado: (2022)

Dynamic Emergence of Observed and Hidden Intra-tumor Heterogeneity
por: Raynaud, Franck, et al.
Publicado: (2019)

epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
por: Chen, Xiaowen, et al.
Publicado: (2021)

Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses
por: Liu, Yongjing, et al.
Publicado: (2022)

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
por: Meiller, Clément, et al.
Publicado: (2021)

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
por: Cresswell, George D., et al.
Publicado: (2016)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
por: Wu, Xiaoxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cfganic17koa5lbg8kobcvtd63